ProPhase Labs, Inc. Business Finance Contracts & Agreements
23 Contracts & Agreements
- Assignment Agreements (1 contract)
- Guaranty Agreements (1)
- Investment Agreements (2)
- Note Agreements (6)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Stock Agreements (5)
- Underwriting Agreements (1)
- Warrant Agreements (2)
- Form of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan (Filed With SEC on March 29, 2023)
- Common Stock Purchase Warrant issued to JXVII Trust, dated January 27, 2023 (Filed With SEC on January 30, 2023)
- Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated January 26, 2023 (Filed With SEC on January 30, 2023)
- Asset Purchase Agreement by and among Stella Diagnostics Inc., Stella DX, LLC and ProPhase Labs, Inc., dated December 15, 2022 (Filed With SEC on December 20, 2022)
- Guaranty dated June 10, 2022 (Filed With SEC on June 13, 2022)
- Stock Purchase Agreement by and among Nebula Genomics, Inc., the Seller Parties Named therein, Kammal Obbad in the capacity as Seller Party Representative, ProPhase Labs, Inc and... (Filed With SEC on August 16, 2021)
- Underwriting Agreement, dated as of January 18, 2021, by and between ProPhase Labs, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc., as representative of... (Filed With SEC on January 20, 2021)
- Form of Securities Purchase Agreement dated January 5, 2021 (Filed With SEC on January 7, 2021)
- Form of Warrant (Filed With SEC on January 7, 2021)
- Stock Purchase Agreement, dated October 22, 2020, by and among Confucius Plaza Medical Laboratory Corp., Pride Diagnostics LLC, the Members of Pride Diagnostics LLC and ProPhase... (Filed With SEC on October 26, 2020)
- Amended and Restated Promissory Note and Security Agreement, dated September 25, 2020, by and between ProPhase Labs, Inc. and Predictive Labs, Inc (Filed With SEC on September 30, 2020)
- Unsecured Convertible Promissory Note and Guaranty issued Justin J. Leonard, dated September 15, 2020 (Filed With SEC on September 18, 2020)
- Unsecured Convertible Promissory Note and Guaranty issued to JXVII Trust, dated September 15, 2020 (Filed With SEC on September 18, 2020)
- Agreement of Sale and Purchase, dated July 10, 2020, by and between ProPhase Labs, Inc. and Lenape Valley Foundation (Filed With SEC on August 25, 2020)
- Description of Common Stock (Filed With SEC on March 26, 2020)
- 12%SECURED PROMISSORY NOTE –SERIES A (Filed With SEC on December 16, 2015)
- ProPhaseLabs, Inc. 12%Secured Promissory Note – Series A andWarrant SUBSCRIPTIONAGREEMENT (Filed With SEC on December 16, 2015)
- EXHIBIT 10.2 Registration Rights Agreement by andbetween ProPhase Labs, Inc. and Dutchess Opportunity Fund, II, LP, datedas of May 28, 2014 (Filed With SEC on May 29, 2014)
- EXHIBIT 10.1 Investment Agreement by and between ProPhaseLabs, Inc. and Dutchess Opportunity Fund, II, LP, datedas of May 28, 2014 (Filed With SEC on May 29, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on November 27, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 27, 2012)
- PROPHASE LABS, INC. AMENDED AND RESTATED 2010 EQUITY COMPENSATION PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on April 25, 2011)
- AGREEMENT ON ASSIGNMENT ANDCOMPENSATION FOR INVENTIONS (Filed With SEC on August 14, 2009)
